tradingkey.logo
tradingkey.logo
Search

Shuttle Pharmaceuticals Holdings Inc

SHPH
Add to Watchlist
2.920USD
0.0000.00%
Close 07-27 16:00ETQuotes delayed by 15 min
1.86MMarket Cap
264.25P/E TTM

SHPH Income Statement

You can find the annual or quarterly income statement of Shuttle Pharmaceuticals Holdings Inc here for insights into the performance and operational efficiency of Shuttle Pharmaceuticals Holdings Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q2
FY2016Q1
FY2015Q4
Total revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating expenses
-24.89%2.22M
56.90%2.79M
-25.71%2.27M
163.75%3.91M
113.11%2.95M
38.53%1.78M
90.82%3.05M
1.16%1.48M
-10.35%1.38M
73.17%1.28M
94.67%1.60M
314.46%1.47M
141.98%1.54M
-25.06%740.79K
239.29%821.47K
5.17%353.63K
262.55%638.40K
--988.54K
--242.12K
--336.25K
--176.09K
--43.87K
-26.27%75.69K
313.82%102.01K
--102.66K
--24.65K
--44.64K
R&D expenses
-83.02%267.24K
-48.11%511.88K
-32.64%943.48K
58.82%1.03M
168.54%1.57M
128.02%986.41K
22.82%1.40M
-30.82%645.72K
-42.02%586.10K
-1.62%432.61K
70.44%1.14M
1012.91%933.37K
241.59%1.01M
-0.55%439.71K
257.85%669.04K
-70.75%83.87K
179.18%295.92K
--442.12K
--186.96K
--286.73K
--106.00K
--15.20K
----
441.19%76.54K
--40.40K
--14.14K
----
Depreciation, depletion, and amortization
62731.35%633.34K
----
27.11%1.01K
----
-47.28%1.01K
-9.43%1.80K
-57.32%793.00
-35.09%962.00
28.49%1.91K
33.27%1.98K
17.22%1.86K
2.28%1.48K
2.62%1.49K
-31.37%1.49K
17.41%1.58K
7.33%1.45K
7.41%1.45K
--2.17K
--1.35K
--1.35K
--1.35K
--4.83K
175.56%4.84K
4.68%4.83K
--1.75K
--4.62K
--4.62K
Other operating expenses
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---1.15K
----
----
----
----
Operating profit
24.89%-2.22M
-56.90%-2.79M
25.71%-2.27M
-163.75%-3.91M
-113.11%-2.95M
-38.53%-1.78M
-90.82%-3.05M
-1.16%-1.48M
10.35%-1.38M
-73.17%-1.28M
-94.67%-1.60M
-314.46%-1.47M
-141.98%-1.54M
25.06%-740.79K
-239.29%-821.47K
-5.17%-353.63K
-262.55%-638.40K
---988.54K
---242.12K
---336.25K
---176.09K
---43.87K
26.27%-75.69K
-313.82%-102.01K
---102.66K
---24.65K
---44.64K
Net non-operating interest income (expenses)
Non-operating interest income
--209.00
17333.33%523.00
-80.74%486.00
-99.43%81.00
-100.00%0.00
-99.99%3.00
-87.84%2.52K
-26.52%14.16K
28.55%21.45K
705.36%22.40K
--20.77K
--19.27K
--16.69K
--2.78K
----
----
----
----
----
----
----
--0.00
-96.48%5.00
-77.64%55.00
--142.00
--246.00
--307.00
Non-operating interest expense
1.61%12.12K
178.43%18.25K
-93.07%18.90K
-94.95%21.74K
-97.60%11.93K
-98.77%6.55K
-56.26%272.68K
-41.16%430.69K
-17.57%497.51K
4023.75%532.05K
0.81%623.47K
295.16%731.94K
286.65%603.57K
-30.95%12.90K
5701.51%618.44K
1636.45%185.23K
1348.46%156.10K
--18.68K
--10.66K
--10.67K
--10.78K
--2.98K
--2.46K
--2.59K
--0.00
--0.00
----
Gains from sale of securities
----
100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-2318.47%-71.57K
--56.40K
2175.40%39.68K
--4.04K
--3.23K
--0.00
--1.74K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
2785.51%76.26K
-12.35%251.50K
100.47%2.43K
106.80%11.67K
-97.90%2.64K
92.91%286.95K
-226.81%-518.77K
-2098.37%-171.74K
-90.02%125.84K
--148.75K
262.68%409.09K
86.63%-7.81K
1019.16%1.26M
-100.00%0.00
214.94%112.80K
-50033.33%-58.42K
95.79%112.66K
--548.17K
--35.81K
--117.00
--57.54K
----
----
----
----
----
----
Other non-operating income (expenses)
100.00%0.00
-100.29%-60.43K
---64.37K
--213.93K
---92.48K
---30.17K
----
--0.00
100.00%0.00
--0.00
-100.00%0.00
--0.00
---104.25K
--0.00
--328.69K
----
----
----
--0.00
----
----
----
----
----
----
----
--17.64K
Income before tax
29.50%-2.15M
-63.59%-2.61M
37.97%-2.35M
-82.48%-3.71M
-76.37%-3.05M
2.56%-1.60M
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-118.47%-1.64M
-79.56%-1.79M
-265.72%-2.18M
-43.01%-975.10K
-63.58%-750.91K
-360.19%-998.42K
-72.22%-597.27K
-427.23%-681.84K
---459.05K
---216.96K
---346.80K
---129.32K
---46.85K
23.78%-78.14K
-328.38%-104.55K
---102.52K
---24.41K
---26.69K
Income tax
----
--50.87M
----
----
----
----
----
----
----
----
--0.00
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
29.50%-2.15M
-63.59%-2.61M
37.97%-2.35M
-82.48%-3.71M
-76.37%-3.05M
2.56%-1.60M
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-118.47%-1.64M
-79.56%-1.79M
-265.72%-2.18M
-43.01%-975.10K
-63.58%-750.91K
-360.19%-998.42K
-72.22%-597.27K
-427.23%-681.84K
---459.05K
---216.96K
---346.80K
---129.32K
---46.85K
23.78%-78.14K
-328.38%-104.55K
---102.52K
---24.41K
---26.69K
Net income from continuous operations
29.50%-2.15M
-63.59%-2.61M
37.97%-2.35M
-82.48%-3.71M
-76.37%-3.05M
2.56%-1.60M
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-118.47%-1.64M
-79.56%-1.79M
-265.72%-2.18M
-43.01%-975.10K
-63.58%-750.91K
-360.19%-998.42K
-72.22%-597.27K
-427.23%-681.84K
---459.05K
---216.96K
---346.80K
---129.32K
---46.85K
23.78%-78.14K
-328.38%-104.55K
---102.52K
---24.41K
---26.69K
Net income attributable to controlling interests
29.50%-2.15M
-63.59%-2.61M
37.97%-2.35M
-82.48%-3.71M
-76.37%-3.05M
2.56%-1.60M
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-118.47%-1.64M
-76.12%-1.79M
-250.60%-2.18M
-37.80%-975.10K
-54.89%-750.91K
-319.36%-1.02M
-67.23%-623.04K
-356.25%-707.61K
---484.81K
---242.73K
---372.57K
---155.09K
---46.85K
23.78%-78.14K
-328.38%-104.55K
---102.52K
---24.41K
---26.69K
Preferred share dividend
----
----
----
----
----
----
----
--0.00
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-24.43%19.47K
0.00%25.77K
0.00%25.77K
--25.76K
--25.77K
--25.77K
--25.77K
----
----
----
----
----
----
Net income attributable to common shareholders
29.50%-2.15M
-63.59%-2.61M
37.97%-2.35M
-82.48%-3.71M
-76.37%-3.05M
2.56%-1.60M
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-118.47%-1.64M
-76.12%-1.79M
-250.60%-2.18M
-37.80%-975.10K
-54.89%-750.91K
-319.36%-1.02M
-67.23%-623.04K
-356.25%-707.61K
---484.81K
---242.73K
---372.57K
---155.09K
---46.85K
23.78%-78.14K
-328.38%-104.55K
---102.52K
---24.41K
---26.69K
Basic earnings per share
43.68%-4.28
93.22%-0.94
33.79%-1.05
-241.11%-3.29
-808.96%-7.60
-1598.79%-13.92
-74.23%-1.59
21.25%-0.96
-46.06%-0.84
-86.27%-0.82
-51.99%-0.91
-226.59%-1.23
-34.24%-0.57
-50.68%-0.44
-310.07%-0.60
-67.20%-0.38
-356.08%-0.43
---0.29
---0.15
---0.22
---0.09
---0.01
23.68%-0.01
-329.63%-0.02
---0.02
--0.00
--0.00
Diluted earnings per share
43.68%-4.28
93.22%-0.94
33.79%-1.05
-241.11%-3.29
-808.96%-7.60
-1598.79%-13.92
-74.23%-1.59
21.25%-0.96
-46.06%-0.84
-86.27%-0.82
-51.99%-0.91
-226.59%-1.23
-34.24%-0.57
-50.68%-0.44
-310.07%-0.60
-67.20%-0.38
-356.08%-0.43
---0.29
---0.15
---0.22
---0.09
---0.01
23.68%-0.01
-329.63%-0.02
---0.02
--0.00
--0.00
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Shuttle Pharmaceuticals Holdings Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing SHPH stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Shuttle Pharmaceuticals Holdings Inc's net income for the year?

Shuttle Pharmaceuticals Holdings Inc posted -11.72M in net income for fiscal year 2025.

How much net income did Shuttle Pharmaceuticals Holdings Inc post in the last quarter?

Shuttle Pharmaceuticals Holdings Inc reported -2.15M in net income for the latest quarter。

What was Shuttle Pharmaceuticals Holdings Inc's annual operating profit?

Shuttle Pharmaceuticals Holdings Inc's operating income was -11.92M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.